UN delays vote on cannabis

CBD Oil - 2,75% - 10ml

It was planned, the UN refuses to honor its commitments

Not surprisingly, the United Nations Commission on Narcotic Drugs (CND) will not vote on the World Health Organization's recommendations on cannabis at its next meeting, the 7 in Vienna.

This ad is not surprising to see usual considering recommendations of the January 24, which were expected in December and were also delayed. The World Health Organization (WHO) has recommended that cannabis be removed from the Fourth Schedule (the one for substances considered to be the most dangerous such as heroin and cocaine) of the 1961 Convention on Drugs and that the principle THC active is removed from the 1971 Convention, and ranked in the first table of the 1961 Annex, thus simplifying the classification of cannabis.

According to the results of the meeting "inter-session" of the CND the 24 February, published on blog, the Expert Committee on Drug Dependence (ECDD) "evaluated four Fentanyls and five synthetic cannabinoids. With regard to the examination of cannabis, the ECDD made several recommendations, including dronabinol and dyes, among others ".

The CND has had the opportunity to vote on the rescheduling of dronabinol since the original WHO proposal for 2012. Dronabinol is a common name for the drug sold under the trade names Marinol and Syndros. The capsules contain one of the psychoactive compounds found in cannabis and are considered "abusive" under Schedule III of the Controlled Substances Act of the United States. Dronabinol is prescribed as an appetite stimulant, relieves sleep apnea and is an antiemetic. It is approved by the FDA as safe and effective for HIV / AIDS-induced anorexia and nausea and vomiting caused by chemotherapy.

Archaic world body

According to the media Marijuana Business Daily the proposal, made by the Expert Committee on Drug Dependence of the World Health Organization, could have a significant impact on the global medical cannabis and hemp industry if it is adopted.

This view is not necessarily accurate, given that UN Member States such as the Canada and Uruguay have already fully legalized, regardless of the position of WHO in this regard. Some courageous countries are progressing faster than the archaic world body can reach a conclusion or the CND will reach consensus.

The recommendations concerning the rescheduling of cannabis were sent to the Member States at the end of January instead of being announced at the 61th session of the CND in Vienna, which would have given them at least three months to discuss the proposals before the vote at the session. Of March.

The proposal to reclassify cannabis was expected by all those who have been fighting for years to regulate the production, consumption and trade of the plant and its derivatives. the fact that the announcement was delayed by a few months will probably not allow a debate at the next session of the UN Commission on Drugs, which will take place in the second half of March, but marks a clear desire to to reform the WHO and put States under the responsibility of responding to necessary rules.

Collective vote postponed

Several of the 53 Member States of the CND have requested additional time for consideration of the recommendations: Japan, which punishes cannabis users with the same harsh penalties as heroin users, United States, where marijuana for medical purposes is legal in 34 states, and recreational use is legal in 11, theGermany, where the herb for medical purposes is already available in German pharmacies, even though they are often in short supply. Representatives of the Norway and theUruguay stressed the importance of not delaying the vote without agreeing on a specific future date.

For Russia : We believe that there is a need for further dialogue on this issue. We welcome the participation of WHO members and ECSD in the sessions of the CND. It will take longer to prepare this discussion. At this point, we ask ourselves the following question: many countries use cannabis and its medical components and these are produced on an industrial scale, what are the current limits given the current schedule?

So far, we do not know how theItaly, who has already reclassified cannabis in 2014, will respond, and what are the government's priorities in terms of policies and the fight against drugs.

On the side of other nations

In general, we see that nations are ready and motivated to make progress, said the Niga © ria.

Ironically, the Venezuela looks forward to the ministerial debate and take decisive action to improve the international drug control system in harmony with human rights. We reiterate the foundations of the result of our understanding: shared and shared responsibility, respect for health, education and human rights, interdisciplinary approach, search for common elements and flexibility, sovereignty of the Member States and non-compliance interference.

According to Turquie: we are among the countries that have tabled a resolution. With regard to precursors, according to the International Narcotics Control Board (INCB), there is a growing problem, we believe that we should keep this issue on the agenda of the CND and find new and effective methods and we will hold informal consultations with interested resolutions. "

In fact, the United Nations Commission on Narcotic Drugs does not need to vote. Participating Member States may, in fact, procrastinate indefinitely on cannabis, as they did with the WHO recommendation to reclassify dronabinol.
Although that probably would not have made much difference, since the vote on dronabinol seems to have been postponed indefinitely ...

Perhaps the member states should continue to progress individually, following the example of Uruguay and Canada, rather than remain idly to passively pontificate and place their hopes in a collective vote constantly postponed .

Recommendation to abolish narcotics offenses

A new UN position paper Calls on Member States to stop criminalizing drug users, to adopt science-based policies and to focus on treatment and harm reduction with a focus on public health and users.

Tags : DrugEuropeLawWHOUNamazing